Drug Shortage Report for UROCIT-K

Last updated on 2021-07-07 History
Report ID 139263
Drug Identification Number 01914022
Brand name UROCIT-K
Common or Proper name Potassium Citrate Extended Release Tablets
Company Name MISSION PHARMACAL COMPANY
Market Status MARKETED
Active Ingredient(s) POTASSIUM CITRATE
Strength(s) 540MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100-ct
ATC code A12BA
ATC description POTASSIUM
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-03-01
Actual start date
Estimated end date 2021-07-30
Actual end date 2021-07-06
Shortage status Resolved
Updated date 2021-07-07
Company comments Delay in confirmation release testing by importer.
Health Canada comments
Tier 3 Status No
Contact Address 10999 IH 10 WEST
SAN ANTONIO, TEXAS
UNITED STATES 78230-1355
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-07-07 English Compare
v9 2021-07-06 French Compare
v8 2021-07-06 English Compare
v7 2021-07-01 French Compare
v6 2021-07-01 English Compare
v5 2021-05-27 French Compare
v4 2021-05-27 English Compare
v3 2021-05-13 French Compare
v2 2021-05-13 English Compare
v1 2021-05-13 English Compare

Showing 1 to 10 of 10